首页> 外文期刊>Neuroscience: An International Journal under the Editorial Direction of IBRO >Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow-derived cells or deletion of the A2A receptor on non-bone marrow-derived cells.
【24h】

Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow-derived cells or deletion of the A2A receptor on non-bone marrow-derived cells.

机译:通过激活骨髓衍生细胞上的腺苷A2A受体或缺失非骨髓衍生细胞上的A2A受体,可以减轻小鼠脊髓压迫损伤。

获取原文
获取原文并翻译 | 示例
           

摘要

Activation of the adenosine A(2A) receptor (A(2A)R) at the time of reperfusion has been shown to reduce ischemia-reperfusion injury in peripheral tissues and spinal cord. In this study we show that treating mice with the A(2A)R agonist, 4-{3-[6-amino-9-(5-cyclopropylcarbamoyl-3,4-dihydroxy-tetrahydro-furan-2-y l)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid methyl ester for four days beginning before or just after the onset of reperfusion after compression-induced spinal cord injury rapidly (within 1 day) and persistently (>42 days) reduces locomotor dysfunction and spinal cord demyelination. Protection is abolished in knockout/wild type bone marrow chimera mice selectively lacking the A(2A)R only on bone marrow-derived cells but retaining receptors on other tissues including blood vessels. Paradoxically, reduced spinal cord injury is also noted in A(2A)R -/- mice, and in wild type/knockout bone marrow chimera mice selectively lacking the A(2A)R on non-bone marrow-derived cells, or in mice treated with the A(2A) antagonist, 4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5]triazin-5-yl-amino]e thyl)phenol. The greatest protection is seen in knockout/wild type bone marrow chimera mice treated with 4-{3-[6-amino-9-(5-cyclopropylcarbamoyl-3,4-dihydroxy-tetrahydro-furan-2-y l)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid methyl ester, i.e. by activating the A(2A)R in mice expressing the receptor only in bone marrow-derived cells. The data suggest that inflammatory bone marrow-derived cells are the primary targets of A(2A) agonist-mediated protection. We conclude that A(2A) agonists or other interventions that inhibit inflammation during and after spinal cord ischemia may be effective in reducing spinal cord injury in patients, but excessive or prolonged stimulation of the A(2A)R may be counterproductive. It may be possible to devise strategies to produce optimal spinal cord protection by exploiting temporal differences in A(2A)R-mediated responses.
机译:已显示在再灌注时激活腺苷A(2A)受体(A(2A)R)可以减少周围组织和脊髓的缺血-再灌注损伤。在这项研究中,我们显示了用A(2A)R激动剂治疗小鼠4- {3- [6-氨基-9-(5-环丙基氨基甲酰基-3,4-二羟基-四氢呋喃-2-基)-9H -嘌呤-2-基]-丙-2-炔基}-哌啶-1-羧酸甲酯连续四天开始,在压缩引起的脊髓损伤后再灌注开始之前或之后(持续1天之内)并持续存在(> 42天)可减轻运动功能障碍和脊髓脱髓鞘。在敲除/野生型骨髓嵌合体小鼠中,仅在骨髓来源的细胞上选择性缺乏A(2A)R,而在包括血管在内的其他组织上保留受体,从而取消了保护。矛盾的是,在A(2A)R-/-小鼠和野生型/基因敲除的骨髓嵌合体小鼠中,在非骨髓来源的细胞或小鼠中选择性缺乏A(2A)R的小鼠中,也注意到脊髓损伤的减轻用A(2A)拮抗剂治疗的4-(2- [7-氨基-2- [2-呋喃基] [1,2,4]三唑[2,3-a] [1,3,5]三嗪- 5-基-氨基]乙基)苯酚。在用4- {3- [6-氨基-9-(5-环丙基氨基甲酰基-3,4-二羟基-四氢呋喃-2-基)-9H-处理的]敲除/野生型骨髓嵌合体小鼠中看到了最大的保护作用嘌呤-2-基]-丙-2-炔基}-哌啶-1-羧酸甲酯,即通过激活仅在骨髓来源的细胞中表达受体的小鼠中的A(2A)R。数据表明,炎症性骨髓来源的细胞是A(2A)激动剂介导的保护的主要目标。我们得出结论,在脊髓缺血期间和之后抑制炎症的A(2A)激动剂或其他干预措施可有效减少患者的脊髓损伤,但过度或长时间刺激A(2A)R可能适得其反。通过利用A(2A)R介导的反应中的时间差异,可以设计出产生最佳脊髓保护作用的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号